Business News • PR NewsWire • Radius Presents Positive Phase 2a Study Results Establishing Clinical Proof of Concept for RAD1901 in Reducing Menopausal Hot Flashes

Radius Presents Positive Phase 2a Study Results Establishing Clinical Proof of Concept for RAD1901 in Reducing Menopausal Hot Flashes

Radius Presents Positive Phase 2a Study Results Establishing Clinical Proof of Concept for RAD1901 in Reducing Menopausal Hot Flashes

CAMBRIDGE, Mass., June 19 /PRNewswire/ -- Radius Health ("Radius") today announced positive results from a Phase 2a clinical trial of the Company's RAD1901 selective estrogen receptor modulator (SERM) in relieving menopausal hot flashes. The data will be presented today in the late-breaking poster s

View More : http://www.prnewswire.com/news-releases/radius-presents-positive-phase-2a-study-results-establishing-clinical-proof-of-c...

Releted News by prnewswire

Mayor Richard M. Daley Joins 100 Community Ambassadors & Interfaith Leaders Working To Bridge Faith & Cultural Divides In Chicago Region

Fructose Hyperbole? Can the Human Body Discern Sugar Sweetened Milk from its High Fructose Corn Syrup Counterpart?

After Making History, Ubiquity Broadcasting Corporation Waits Out the Big Waves to Showcase Its Ground-Breaking Technology Again, Next Week, While Broadcasting Day 2 of the Sponsor Me Ala Moana Bowls Contest Live in HD on all Three Screens (the Inte

Pennsylvania Governor Rendell Honors Harrisburg Chefs for Commitment to Culinary Excellence